Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4822)
All Articles published online
|
Oct 14, 2012 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Li J, Jia L, Ma ZH, Ma QH, Yang XH, Zhao YF. Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma. World J Gastroenterol 2012; 18(38): 5369-5376 [PMID: 23082053 DOI: 10.3748/wjg.v18.i38.5369] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i38/5369.htm |
| Number | Citing Articles |
| 1 |
Mingrong Cheng, Dejian Dai. Inhibitory of active dual cancer targeting 5-Fluorouracil nanoparticles on liver cancer in vitro and in vivo. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.971475
|
| 2 |
Nataliya Pidkovka, Abbes Belkhiri. Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1079041
|
| 3 |
Cunhua Shao, Gongpan Liu, Xiaobin Zhang, Anyun Li, Xingjun Guo. <p>Long Noncoding RNA RMRP Suppresses the Tumorigenesis of Hepatocellular Carcinoma Through Targeting microRNA-766</p>. OncoTargets and Therapy 2020; : 3013 doi: 10.2147/OTT.S243736
|
| 4 |
Natalia Porębska, Marta Poźniak, Aleksandra Matynia, Dominika Żukowska, Małgorzata Zakrzewska, Jacek Otlewski, Łukasz Opaliński. Galectins as modulators of receptor tyrosine kinases signaling in health and disease. Cytokine & Growth Factor Reviews 2021; 60: 89 doi: 10.1016/j.cytogfr.2021.03.004
|
| 5 |
Yanyan Li, Li Jia, Chen Liu, Yanxin Gong, Dongliang Ren, Ning Wang, Xu Zhang, Yongfu Zhao. Axl as a downstream effector of TGF-β1 via PI3K/Akt-PAK1 signaling pathway promotes tumor invasion and chemoresistance in breast carcinoma. Tumor Biology 2015; 36(2): 1115 doi: 10.1007/s13277-014-2677-3
|
| 6 |
Retraction: Modification of Glycosylation Mediates the Invasive Properties of Murine Hepatocarcinoma Cell Lines to Lymph Nodes. PLOS ONE 2019; 14(9): e0222417 doi: 10.1371/journal.pone.0222417
|
| 7 |
XIAO-YUN LI, JING-YUN WEN, CHANG-CHANG JIA, TIAN-TIAN WANG, XING LI, MIN DONG, QU LIN, ZHAN-HONG CHEN, XIAO-KUN MA, LI WEI, ZE-XIAO LIN, DAN-YUN RUAN, JIE CHEN, DONG-HAO WU, WEI LIU, YAN TAI, ZHI-YONG XIONG, XIANG-YUAN WU, QI ZHANG. MicroRNA-34a-5p enhances sensitivity to chemotherapy by targeting AXL in hepatocellular carcinoma MHCC-97L cells. Oncology Letters 2015; 10(5): 2691 doi: 10.3892/ol.2015.3654
|
| 8 |
Sierra A. Colavito. AXL as a Target in Breast Cancer Therapy. Journal of Oncology 2020; 2020: 1 doi: 10.1155/2020/5291952
|
| 9 |
Haley Axelrod, Kenneth J. Pienta. Axl as a mediator of cellular growth and survival. Oncotarget 2014; 5(19): 8818 doi: 10.18632/oncotarget.2422
|
| 10 |
Rumeysa Ozyurt, Bulent Ozpolat. Therapeutic Landscape of AXL Receptor Kinase in Triple-Negative Breast Cancer. Molecular Cancer Therapeutics 2023; 22(7): 818 doi: 10.1158/1535-7163.MCT-22-0617
|
| 11 |
Jingchao Xu, Li Jia, Hongye Ma, Yanping Li, Zhenhai Ma, Yongfu Zhao. Axl gene knockdown inhibits the metastasis properties of hepatocellular carcinoma via PI3K/Akt-PAK1 signal pathway. Tumor Biology 2014; 35(4): 3809 doi: 10.1007/s13277-013-1521-5
|
| 12 |
Jian Wu, Hongqiang Qin, Ting Li, Kai Cheng, Jiaqiang Dong, Miaomiao Tian, Na Chai, Hao Guo, Jinjing Li, Xin You, Mingming Dong, Mingliang Ye, Yongzhan Nie, Hanfa Zou, Daiming Fan. Characterization of site-specific glycosylation of secreted proteins associated with multi-drug resistance of gastric cancer. Oncotarget 2016; 7(18): 25315 doi: 10.18632/oncotarget.8287
|
| 13 |
Kinjal Bhadresha, Sheefa Mirza, Clement Penny, Muhammed Jameel Mughal. Targeting AXL in mesothelioma: From functional characterization to clinical implication. Critical Reviews in Oncology/Hematology 2023; 188: 104043 doi: 10.1016/j.critrevonc.2023.104043
|
| 14 |
Dongliang Ren, Yanyan Li, Yanxin Gong, Jingchao Xu, Xiaolong Miao, Xiangnan Li, Chen Liu, Li Jia, Yongfu Zhao. Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors. Tumor Biology 2014; 35(10): 9603 doi: 10.1007/s13277-014-2254-9
|
| 15 |
Markus Lauter, Anja Weber, Robert Torka. Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation. Cell Communication and Signaling 2019; 17(1) doi: 10.1186/s12964-019-0377-8
|
| 16 |
Jared Kirui, Yara Abidine, Annasara Lenman, Koushikul Islam, Yong-Dae Gwon, Lisa Lasswitz, Magnus Evander, Marta Bally, Gisa Gerold. The Phosphatidylserine Receptor TIM-1 Enhances Authentic Chikungunya Virus Cell Entry. Cells 2021; 10(7): 1828 doi: 10.3390/cells10071828
|
| 17 |
Cheng-Fen Tu, Fu-An Li, Ling-Hui Li, Ruey-Bing Yang. Quantitative glycoproteomics analysis identifies novel FUT8 targets and signaling networks critical for breast cancer cell invasiveness. Breast Cancer Research 2022; 24(1) doi: 10.1186/s13058-022-01513-3
|
| 18 |
Naeun Lee, Won-Jun Jang, Ji Hae Seo, Sooyeun Lee, Chul-Ho Jeong. 2-Deoxy-d-Glucose-Induced Metabolic Alteration in Human Oral Squamous SCC15 Cells: Involvement of N-Glycosylation of Axl and Met. Metabolites 2019; 9(9): 188 doi: 10.3390/metabo9090188
|